Informing candidates for solid-organ transplantation about donor risk factors.

PubWeight™: 2.83‹?› | Rank: Top 1%

🔗 View Article (PMID 18579820)

Published in N Engl J Med on June 26, 2008

Authors

Scott D Halpern1, Abraham Shaked, Richard D Hasz, Arthur L Caplan

Author Affiliations

1: Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, USA.

Articles citing this

Deceased organ donation consent rates among racial and ethnic minorities and older potential donors. Crit Care Med (2013) 3.22

Informed consent in research to improve the number and quality of deceased donor organs. Crit Care Med (2011) 2.18

Variation in organ quality between liver transplant centers. Am J Transplant (2011) 1.99

Regulated payments for living kidney donation: an empirical assessment of the ethical concerns. Ann Intern Med (2010) 1.83

Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42

PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep (2013) 1.17

Twenty-four-hour intensivist staffing in teaching hospitals: tensions between safety today and safety tomorrow. Chest (2012) 1.12

Patient decision making about organ quality in liver transplantation. Liver Transpl (2011) 1.04

Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection. Clin J Am Soc Nephrol (2010) 1.03

Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use. Am J Transplant (2009) 0.94

Informing candidates for transplantation about donor risk factors. N Engl J Med (2008) 0.92

Vascularized Composite Allografts: Procurement, Allocation, and Implementation. Curr Transplant Rep (2015) 0.82

Guidelines for the assessment and acceptance of potential brain-dead organ donors. Rev Bras Ter Intensiva (2016) 0.81

Viral infection in renal transplant recipients. ScientificWorldJournal (2012) 0.79

Informing candidates for transplantation about donor risk factors. N Engl J Med (2008) 0.75

Brain death and care of the organ donor. J Anaesthesiol Clin Pharmacol (2016) 0.75

What Kind of Information About Marginal Donors Is Available Through Sources Other Than Health Care Professionals for Patients on the Waiting List for Organ Transplantation? Interact J Med Res (2015) 0.75

New Solutions to Reduce Discard of Kidneys Donated for Transplantation. J Am Soc Nephrol (2015) 0.75

Ushering in the era of penile transplantation. Transl Androl Urol (2017) 0.75

Articles by these authors

(truncated to the top 100)

All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth (2003) 12.38

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (2012) 4.20

Nudge, nudge or shove, shove-the right way for nudges to increase the supply of donated cadaver organs. Am J Bioeth (2012) 3.43

Solid-organ transplantation in HIV-infected patients. N Engl J Med (2002) 3.34

Conflicts of interest in cardiovascular clinical practice guidelines. Arch Intern Med (2011) 3.29

Consent and anonymization in research involving biobanks: differing terms and norms present serious barriers to an international framework. EMBO Rep (2006) 3.27

Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology (2008) 2.95

Pediatric euthanasia in Belgium: disturbing developments. JAMA (2014) 2.89

Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72

Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63

Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog (2009) 2.57

Thomas Szasz: rebel with a questionable cause. Lancet (2012) 2.23

Should physicians participate in capital punishment? Mayo Clin Proc (2007) 2.21

Informed consent in research to improve the number and quality of deceased donor organs. Crit Care Med (2011) 2.18

The Children's Hospital of Philadelphia's experience with donation after cardiac death. Crit Care Med (2008) 2.14

Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders. Lancet (2013) 2.12

Will evidence ever be sufficient to resolve the challenge of cost containment? J Clin Oncol (2011) 2.11

Can applied ethics be effective in health care and should it strive to be? Ethics (1983) 1.96

Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl (2004) 1.95

Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl (2005) 1.87

The OHRP and SUPPORT. N Engl J Med (2013) 1.78

All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth (2010) 1.74

Reuse of pacemakers and defibrillators in developing countries: logistical, legal, and ethical barriers and solutions. Heart Rhythm (2010) 1.74

Creating a medical, ethical, and legal framework for complex living kidney donors. Clin J Am Soc Nephrol (2006) 1.74

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl (2006) 1.72

Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol (2004) 1.68

Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis. Addiction (2012) 1.58

Transplantation: impact of pretransplant renal insufficiency. Liver Transpl (2008) 1.58

Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl (2010) 1.56

Human subjects in weapons research. Science (2002) 1.47

Embryo disposal practices in IVF clinics in the United States. Politics Life Sci (2004) 1.46

Is disease eradication ethical? Lancet (2009) 1.46

Ethical engineers need not apply: the state of applied ethics today. Sci Technol Human Values (1980) 1.45

Genital warts: mountains or molehills? Lancet Infect Dis (2008) 1.45

Protecting subjects' interests in genetics research. Am J Hum Genet (2002) 1.45

Caring for organs or for patients? Ethical concerns about the Uniform Anatomical Gift Act (2006). Ann Intern Med (2007) 1.45

An under-recognized benefit of cardiopulmonary resuscitation: organ transplantation. Crit Care Med (2013) 1.41

Ascites after liver transplantation--a mystery. Liver Transpl (2004) 1.40

Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol (2010) 1.39

Risk, consent, and SUPPORT. N Engl J Med (2013) 1.29

Donor-derived Strongyloides stercoralis infections in renal transplant recipients. Transplantation (2011) 1.29

Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am J Gastroenterol (2003) 1.23

Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology (2002) 1.23

A proposed ethical framework for vaccine mandates: competing values and the case of HPV. Kennedy Inst Ethics J (2008) 1.21

Estimated supply of organ donors after circulatory determination of death: a population-based cohort study. JAMA (2010) 1.21

Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant (2004) 1.20

Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19

Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13

Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology (2014) 1.12

Routine HIV testing in dental practice: can we cross the Rubicon? J Dent Educ (2007) 1.11

A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl (2007) 1.10

Exempting schoolchildren from immunizations: states with few barriers had highest rates of nonmedical exemptions. Health Aff (Millwood) (2013) 1.08

Vaccination refusal: ethics, individual rights, and the common good. Prim Care (2011) 1.07

Duty to warn?-the ethics of disclosing information about possible risks associated with H1N1 vaccination. Sleep (2010) 1.05

Ethical issues surrounding fertility preservation in cancer patients. Clin Obstet Gynecol (2010) 1.03

Taking ethics seriously in cosmetic dermatology. Arch Dermatol (2006) 1.03

Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01

Successes and failures of hospital ethics committees: a national survey of ethics committee chairs. Camb Q Healthc Ethics (2002) 1.00

The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation (2002) 0.98

Why autonomy needs help. J Med Ethics (2012) 0.97

Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction management. Acta Neurochir (Wien) (2011) 0.96

Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant (2005) 0.95

Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma. Cancer (2011) 0.94

Toward further expansion of the organ pool for adult liver recipients: splitting the cadaveric liver into right and left lobes. Transplantation (2002) 0.94

Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation (2004) 0.93

Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl (2012) 0.93

Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. World J Gastroenterol (2005) 0.93

Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantation. Transplantation (2004) 0.91

Doctors choosing not to be vaccinated is choosing to do harm. BMJ (2011) 0.90

Late surgical complications following liver transplantation. Liver Transpl (2009) 0.90

Accepting brain death. N Engl J Med (2014) 0.90

Dexamethasone inhibits early regenerative response of rat liver after cold preservation and transplantation. Hepatology (2003) 0.89

How should we use age to ration health care? Lessons from the case of kidney transplantation. J Am Geriatr Soc (2010) 0.89

Is there a duty to serve as a subject in biomedical research? IRB (1985) 0.88

Severe preservation injury induces Il-6/STAT3 activation with lack of cell cycle progression after partial liver graft transplantation. Am J Transplant (2004) 0.88

Survival among pediatric liver transplant recipients: impact of segmental grafts. Liver Transpl (2004) 0.86

Medical ethics: Code of Medical Ethics: Current Opinions With Annotations. JAMA (1995) 0.86

Better off living--the ethics of the new UNOS proposal for allocating kidneys for transplantation. Clin J Am Soc Nephrol (2011) 0.85

Misusing the Nazi analogy. Science (2005) 0.85

The HPV vaccine controversy. Virtual Mentor (2012) 0.85

Players' Doctors: The Roles Should Be Very Clear. Hastings Cent Rep (2016) 0.85

Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data. Liver Transpl (2011) 0.84

Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases. Leuk Lymphoma (2007) 0.84

Appendicitis among liver transplant recipients. Liver Transpl (2005) 0.83

Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma. J Gastrointestin Liver Dis (2009) 0.83

Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg (2015) 0.82

Immunosuppression and hepatocellular carcinoma. Liver Transpl (2011) 0.82

Transplant ethics under scrutiny - responsibilities of all medical professionals. Croat Med J (2013) 0.82

The history and evolution of hand transplantation. Hand Clin (2011) 0.82

Transplantation at any price? Am J Transplant (2004) 0.82

Editorial position on publishing articles on human organ transplantation. J Clin Invest (2012) 0.82

The case for vaccinating boys against human papillomavirus. Public Health Genomics (2009) 0.81

Living donation: focus on public concerns. Clin Transplant (2005) 0.81

Screening practices and beliefs of assisted reproductive technology programs. Fertil Steril (2005) 0.81

Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation. Clin Transplant (2007) 0.81

Ethics of bioengineering organs and tissues. Expert Opin Biol Ther (2014) 0.81

Are required request laws working? Altruism and the procurement of organs and tissues. Clin Transplant (1989) 0.81

Biliary complications adversely affect patient and graft survival after liver retransplantation. Liver Transpl (2013) 0.81

Potential suitability for transplantation of hearts from human non-heart-beating donors: data review from the Gift of Life Donor Program. J Heart Lung Transplant (2005) 0.80